At one point yesterday, Liberator Medical (LBMH) dropped over 33% on no news. It closed at 4.68, and throughout it all, we have continued to hold onto our position in the company, which we have followed closely since 2010. We do not see any changes in the business model that make us concerned, and instead, only see continued improvement. Our thesis from the prior article before is still intact, and we urge readers to take a closer look at the business and make an educated decision for themselves.
When we last mentioned LBMH (article here), the stock was trading at $2/share and valued at 4x EV/EBITDA. In the last few months, LBMH became listed on the...
Only subscribers can access this article, which is part of the PRO research library covering 3,556 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: